Meta-analysis of 7 observational studies (21,244 patients with rheumatoid arthritis): selective JAK1 inhibitors were associated with lower discontinuation than pan-JAK inhibitors (HR 0.72), mainly for lack of efficacy (HR 0.68); adverse-event and infection stops were similar.
Meta-analysisn = 21,244
Lee et al. Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence